athenahealth price target raised to $140 from $105 at LeerinkLeerink analyst David Larsen raised his price target for athenahealth to $140 citing the involvement of activist investor Elliott Associates. Elliott has run a "large number of successful campaigns" that have resulted in returns of 26%-plus across a large sample of investments, Larsen tells investors in a research note. He expects the activist to pursue a "wide array of strategic options" in an effort to unlock shareholder value. Larsen keeps a Market Perform rating on athenahealth. |